Abstract
ABSTRACTThe MYC and NMYC transcription factors (TFs) play a key role in cell proliferation and are overexpressed in most cancer cells. However, in normal cells their overexpression triggers safeguard mechanisms promoting cell death and cellular senescence, which are bypassed in cancer cells. The mechanisms of action of this TF family are only partially understood. Here, we reveal that in normal cells MYC binds to the Inositol 1,4,5-Trisphosphate Receptor type 1 (ITPR1)gene and upregulates its expression, triggering an ER-mitochondria calcium (Ca2+) transfer, which is involved in MYC-induced cell death and senescence. Supporting a tumor suppressive role of MYC/ITPR1 axis,ITPR1expression is generally decreased in cancer and reactivation of this pathway induces cancer cell death. Nevertheless, some cancer cells, generally expressing high levels ofMYCNand/orMYC, also express high level ofITPR1, which correlates with high expression ofBCL2, encoding an inhibitor of ITPR1. Strikingly, in high-riskMYCN-amplified neuroblastoma,ITPR1expression is controlled by NMYC and its level correlates with worse patient survival. In these cells, blocking the interaction between BCL2 and ITPR1 induces mitochondrial Ca2+accumulation and cell death, and decreases tumor size. Collectively these data highlight a new function of MYC factors by controlling Ca2+signaling, which could constitute an unsuspected vulnerability for some cancer cells, including high-riskMYCN-amplified neuroblastoma cells.
Publisher
Cold Spring Harbor Laboratory